MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 28.3868

Change

+0.07 (+0.24)%

Market Cap

N/A

Volume

405.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-2.12 (-3.78%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

-4.57 (-2.07%)

USD 42.88B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.83 (-1.42%)

USD 22.89B
ACWI iShares MSCI ACWI ETF

-1.68 (-1.36%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

+0.12 (+0.68%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-5.44 (-8.27%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.04 (+0.08%)

USD 4.81B
TSLL Direxion Shares ETF Trust - Di..

-1.90 (-9.50%)

USD 4.32B
ETHA iShares Ethereum Trust ETF

-0.98 (-4.70%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-1.26 (-1.71%)

USD 2.37B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.64% 87% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.64% 87% B+ 78% C+
Trailing 12 Months  
Capital Gain -5.16% 21% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.16% 20% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.10% 38% F 38% F
Dividend Return -0.10% 30% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.12% 89% A- 97% N/A
Risk Adjusted Return -3.25% 30% F 32% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector